231 related articles for article (PubMed ID: 37161591)
1. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Long L; Xiong W; Lin F; Hou J; Chen G; Peng T; He Y; Wang R; Xu Q; Huang Y
J Exp Clin Cancer Res; 2023 May; 42(1):117. PubMed ID: 37161591
[TBL] [Abstract][Full Text] [Related]
2. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract][Full Text] [Related]
3. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.
Zhu J; Wang R; Yang C; Shao X; Zhang Y; Hou J; Gao Y; Ou A; Chen M; Huang Y
J Control Release; 2024 Feb; 366():328-341. PubMed ID: 38168561
[TBL] [Abstract][Full Text] [Related]
4. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
[TBL] [Abstract][Full Text] [Related]
5. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
Chen J; Xie J; Jiang Z; Wang B; Wang Y; Hu X
Oncogene; 2011 Oct; 30(42):4297-306. PubMed ID: 21516121
[TBL] [Abstract][Full Text] [Related]
6. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
[TBL] [Abstract][Full Text] [Related]
7. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
8. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
[TBL] [Abstract][Full Text] [Related]
9. Acidic and hypoxic tumor microenvironment regulation by CaO
Ruan S; Yin W; Chang J; Yang Y; Sun J; Ma X; Liu Y; Zang J; Liu Y; Li Y; Ren T; Dong H
J Nanobiotechnology; 2022 Dec; 20(1):544. PubMed ID: 36577992
[TBL] [Abstract][Full Text] [Related]
10. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatment.
Ma Y; Lai X; Wen Z; Zhou Z; Yang M; Chen Q; Wang X; Mei F; Yang L; Yin T; Sun S; Lu G; Qi J; Lin H; Han H; Yang Y
Bioorg Chem; 2023 Oct; 139():106703. PubMed ID: 37399615
[TBL] [Abstract][Full Text] [Related]
13. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.
Hamabe A; Konno M; Tanuma N; Shima H; Tsunekuni K; Kawamoto K; Nishida N; Koseki J; Mimori K; Gotoh N; Yamamoto H; Doki Y; Mori M; Ishii H
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15526-31. PubMed ID: 25313085
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
Santagata S; Rea G; Castaldo D; Napolitano M; Capiluongo A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Di Maro S; Tatangelo F; Albino V; Guarino R; Cutolo C; Izzo F; Scala S
Hepatol Int; 2024 Apr; 18(2):568-581. PubMed ID: 37142825
[TBL] [Abstract][Full Text] [Related]
15. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
[TBL] [Abstract][Full Text] [Related]
16. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
Yang W; Liu J; Hou L; Chen Q; Liu Y
Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
[TBL] [Abstract][Full Text] [Related]
17. PKM2 regulates cigarette smoke-induced airway inflammation and epithelial-to-mesenchymal transition via modulating PINK1/Parkin-mediated mitophagy.
Li D; Shen C; Liu L; Hu J; Qin J; Dai L; Gao L; Cheng M; Wang D; Bao R; Wang B
Toxicology; 2022 Jul; 477():153251. PubMed ID: 35787437
[TBL] [Abstract][Full Text] [Related]
18. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
20. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
Qin JZ; Upadhyay V; Prabhakar B; Maker AV
J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
